{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:10:46Z","timestamp":1789560646339,"version":"build-2803163510"},"reference-count":16,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["arthroscopyjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Arthroscopy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Intra\u2010articular platelet\u2010rich plasma (PRP) is among the most frequently administered orthobiologic treatments for symptomatic knee osteoarthritis. PRP is not a single intervention. Preparations differ in platelet concentration, total platelet dose, leukocyte and erythrocyte content, injection volume, activation method, and injection interval, such that 2 products sharing the acronym may constitute fundamentally different biologic treatments. The randomized literature supports a small symptomatic advantage of PRP over hyaluronic acid in mild\u2010to\u2010moderate disease. That advantage appears to emerge at 12\u2009months rather than early and is best framed as symptom modification rather than cartilage regeneration. Whether any particular formulation drives the effect is far less certain. Reported associations between platelet concentration, leukocyte enrichment, activation status, and outcome are biologically plausible, yet they are typically carried by small and heavily overlapping sets of trials in which these variables cannot be separated from one another. Platelet concentration is furthermore not equivalent to platelet dose, which is the product of concentration and injection volume. Until absolute dose, leukocyte composition, activation, and final volume are consistently reported, comparisons of high versus low concentration remain uninterpretable. In our practice, PRP and hyaluronic acid are increasingly combined for a theoretical synergistic impact because viscosupplementation and biologic signaling address distinct components of the osteoarthritic joint. Standardized product characterization, dose\u2010defined randomized trials, responder\u2010based outcomes, and improved patient selection are warranted. The acronym is not the prescription; the product is.<\/jats:p>","DOI":"10.1002\/arj.70588","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:54:07Z","timestamp":1789559647000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["<i>Editorial Commentary<\/i>\n                    : Platelet\u2010Rich Plasma Outlasts Hyaluronic Acid for Knee Osteoarthritis, but the Product, Not the Acronym, Is the Prescription"],"prefix":"10.1002","author":[{"given":"Jakob","family":"Ackermann","sequence":"first","affiliation":[{"name":"Midwest Orthopaedics at Rush  Chicago Illinois U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Kao","sequence":"additional","affiliation":[{"name":"Midwest Orthopaedics at Rush  Chicago Illinois U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee R.","family":"Friedman","sequence":"additional","affiliation":[{"name":"Midwest Orthopaedics at Rush  Chicago Illinois U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Sassower","sequence":"additional","affiliation":[{"name":"Midwest Orthopaedics at Rush  Chicago Illinois U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Chiampas","sequence":"additional","affiliation":[{"name":"Midwest Orthopaedics at Rush  Chicago Illinois U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Cole","sequence":"additional","affiliation":[{"name":"Midwest Orthopaedics at Rush  Chicago Illinois U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"e_1_2_3_2_1","article-title":"Platelet\u2010rich plasma provides small but superior short\u2010term pain relief and functional improvement compared with hyaluronic acid for the treatment of knee osteoarthritis: A systematic review and meta\u2010analysis","author":"Zhong C","year":"2026","journal-title":"Arthroscopy."},{"key":"e_1_2_3_3_1","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s10067-018-3985-6","article-title":"Comparison of hyaluronic acid and PRP intra\u2010articular injection with combined intra\u2010articular and intraosseous PRP injections to treat patients with knee osteoarthritis","volume":"37","author":"Su K","year":"2018","journal-title":"Clin Rheumatol."},{"key":"e_1_2_3_4_1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00167-016-4110-5","article-title":"Choice of intra\u2010articular injection in treatment of knee osteoarthritis: Platelet\u2010rich plasma, hyaluronic acid or ozone options","volume":"25","author":"Duymus TM","year":"2017","journal-title":"Knee Surg Sports Traumatol Arthrosc."},{"key":"e_1_2_3_5_1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jor.2020.01.041","article-title":"Comparison of 2 platelet rich plasma formulations with viscosupplementation in treatment of moderate grade gonarthrosis: A prospective randomized controlled study","volume":"20","author":"Yaradilmis YU","year":"2020","journal-title":"J Orthop."},{"key":"e_1_2_3_6_1","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2106\/JBJS.16.00793","article-title":"Minimum information for studies evaluating biologics in orthopaedics (MIBO): Platelet\u2010Rich plasma and mesenchymal stem cells","volume":"99","author":"Murray IR","year":"2017","journal-title":"J Bone Joint Surg Am."},{"key":"e_1_2_3_7_1","doi-asserted-by":"crossref","first-page":"e000060","DOI":"10.1136\/bmjsem-2015-000060","article-title":"DEPA classification: A proposal for standardising PRP use and a retrospective application of available devices","volume":"2","author":"Magalon J","year":"2016","journal-title":"BMJ Open Sport Exerc Med."},{"key":"e_1_2_3_8_1","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.arthro.2012.04.148","article-title":"Platelet\u2010rich plasma: The PAW classification system","volume":"28","author":"DeLong JM","year":"2012","journal-title":"Arthroscopy."},{"key":"e_1_2_3_9_1","doi-asserted-by":"crossref","first-page":"104453","DOI":"10.1016\/j.otsr.2025.104453","article-title":"Influence of platelet count on the clinical effectiveness of platelet\u2010rich plasma in the treatment of knee osteoarthritis: A systematic review and meta\u2010analysis","author":"Simental\u2010Mendia M","year":"2025","journal-title":"Orthop Traumatol Surg Res."},{"key":"e_1_2_3_10_1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1177\/03635465241246524","article-title":"PRP injections for the treatment of knee osteoarthritis: The improvement is clinically significant and influenced by platelet concentration: A meta\u2010analysis of randomized controlled trials","volume":"53","author":"Bensa A","year":"2025","journal-title":"Am J Sports Med."},{"key":"e_1_2_3_11_1","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.arthro.2024.03.018","article-title":"A greater platelet dose may yield better clinical outcomes for platelet\u2010rich plasma in the treatment of knee osteoarthritis: A systematic review","volume":"41","author":"Berrigan WA","year":"2025","journal-title":"Arthroscopy."},{"key":"e_1_2_3_12_1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/03635465211064303","article-title":"Leukocyte\u2010rich versus leukocyte\u2010poor platelet\u2010rich plasma for the treatment of knee osteoarthritis: A double\u2010blind randomized trial","volume":"50","author":"Di Martino A","year":"2022","journal-title":"Am J Sports Med."},{"key":"e_1_2_3_13_1","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1007\/s00402-024-05603-z","article-title":"Efficacy of intra\u2010articular injection of combined platelet\u2010rich\u2010plasma (PRP) and hyaluronic acid (HA) in knee degenerative joint disease: A prospective, randomized, double\u2010blind clinical trial","volume":"144","author":"Fossati C","year":"2024","journal-title":"Arch Orthop Trauma Surg."},{"key":"e_1_2_3_14_1","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.arthro.2020.11.052","article-title":"Platelet\u2010rich plasma combined with hyaluronic acid improves pain and function compared with hyaluronic acid alone in knee osteoarthritis: A systematic review and meta\u2010analysis","volume":"37","author":"Karasavvidis T","year":"2021","journal-title":"Arthroscopy."},{"key":"e_1_2_3_15_1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/0363546521998010","article-title":"Treating knee osteoarthritis with platelet\u2010rich plasma and hyaluronic acid combination therapy: A systematic review","volume":"50","author":"Baria MR","year":"2022","journal-title":"Am J Sports Med."},{"key":"e_1_2_3_16_1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ksa.12077","article-title":"The use of injectable orthobiologics for knee osteoarthritis: A European ESSKA\u2010ORBIT consensus. Part 1\u2010Blood\u2010derived products (platelet\u2010rich plasma)","volume":"32","author":"Laver L","year":"2024","journal-title":"Knee Surg Sports Traumatol Arthrosc."},{"key":"e_1_2_3_17_1","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1002\/ksa.12320","article-title":"Platelet\u2010rich plasma injections for the management of knee osteoarthritis: The ESSKA\u2010ICRS consensus. Recommendations using the RAND\/UCLA appropriateness method for different clinical scenarios","volume":"32","author":"Kon E","year":"2024","journal-title":"Knee Surg Sports Traumatol Arthrosc."}],"container-title":["Arthroscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/arthroscopyjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/arj.70588","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/arthroscopyjournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/arj.70588","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/arthroscopyjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/arj.70588","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:54:10Z","timestamp":1789559650000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthroscopyjournals.onlinelibrary.wiley.com\/doi\/10.1002\/arj.70588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":16,"alternative-id":["10.1002\/arj.70588"],"URL":"https:\/\/doi.org\/10.1002\/arj.70588","archive":["Portico"],"relation":{},"ISSN":["0749-8063","1526-3231"],"issn-type":[{"value":"0749-8063","type":"print"},{"value":"1526-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"2026-09-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"arj.70588"}}